<DOC>
	<DOC>NCT02588378</DOC>
	<brief_summary>This prospective, non-therapeutic study will compare the relative utility of multiple ocular imaging modalities in the detection of the cellular immune response in patients with AMD and related disorders.</brief_summary>
	<brief_title>The Role of Inflammation in AMD and Related Disorders</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Inclusion Criteria STUDY EYE Any tentative clinical diagnosis of the following: 1. Early dry AMD (drusen) with clinical suspicion of CNV 2. Late dry AMD (GA) with clinical suspicion of CNV 3. Reticular Pseudodrusen with clinical suspicion of CNV 4. Polypoidal choroidal vasculopathy 5. Retinal Angiomatous Proliferation 6. Central Serous Retinopathy 7. RPE detachment 8. Conversion to wet AMD (CNV) 9. Decade matched controls Inclusion Criteria CONTROL EYE Subjects &gt; 18 years of age Best corrected visual acuity (BCVA) of 20/32 or better Exclusion Criteria STUDY/CONTROL EYE: Patients not able to provide consent for the study. Patients with a poor view of the fundus due to cataract or vitreous hemorrhage. Patients &lt; 18 years of age Patients with known allergy to angiographic dye Patients with any concurrent unrelated eye diagnosis that would interfere with image acquisition or interpretation (eg advanced diabetic retinopathy, vascular occlusion, uveitis, or others). Exclusion Criteria CONTROL EYE Suspect diagnosis of AMD, RPD, PCV, RAP, CSR or RPED Family history of AMD 2 or more large drusen (&gt;125um) or 20 or more medium drusen (64124um) Diabetes Patients using Plaquenil/Chloroquine/Hydroxychloroquine Diagnosis of inflammatory disease Patients with inherited eye disease Note: patients with a diagnosis of nevi are NOT excluded from this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>